Daniel Ayoubkhani

1 week ago | nature.com | Lauren O’Mahoney |Ash Routen |Abdullah Almaqhawi |Daniel Ayoubkhani |Amitava Banerjee |Melanie Calvert | +9 more

AbstractThe global evidence on the risk of symptoms of Long Covid in general populations infected with SARS-CoV-2 compared to uninfected comparator/control populations remains unknown. We conducted a systematic literature search using multiple electronic databases from January 1, 2022, to August 1, 2024. Included studies had ≥100 people with confirmed or self-reported COVID-19 at ≥28 days following infection onset, and an uninfected comparator/control group.

May 22, 2023 | theconversation.com | Nisreen A Alwan |Daniel Ayoubkhani

Almost 2 million people in the UK are estimated to be living with long COVID – after-effects of COVID that can persist for months or even years after the initial infection. Common symptoms include fatigue, breathlessness, muscle and joint pain, cognitive impairment and sleep disruption. People with long COVID also have a higher risk of developing serious heart and lung problems, stroke and blood clots compared to those who have not previously been diagnosed with COVID.